NasdaqGS:TMCIMedical Equipment
Treace Medical Concepts (TMCI) Q4 Loss Narrowing To US$0.15 EPS Tests Bearish Narratives
Treace Medical Concepts (TMCI) just posted its FY 2025 fourth quarter numbers with revenue of US$62.5 million and a basic EPS loss of US$0.15, while the trailing 12 month figures show revenue of US$212.7 million and a basic EPS loss of US$0.93, set against roughly 4% revenue growth on a trailing basis. Over recent quarters, the company has seen revenue move from US$45.1 million in Q3 2024 to US$52.6 million in Q1 2025, US$47.4 million in Q2 2025, US$50.2 million in Q3 2025 and US$62.5 million...